Patent · US Active

Methods of using pyruvate kinase activators

US11234976B2 · kind B2 · utility

1Cited by

69References

16Claims

0Family size

Assignee

Agios Pharmaceuticals, Inc. · US

Inventors

Samuel V. Agresta · Lexington, US
Yue Chen · Tianjin, CN
Marvin B. Cohen · Newtown, US
Lenny Dang · Boston, US
Charles Kung · Arlington, US
Elizabeth A. Merica · Boston, US
Bruce A. Silver · Dunkirk, US
Hua Yang · Delta, CA

Key dates

Filing date	Jun 10, 2016
Grant date	Feb 1, 2022
Priority date	—
Expiry date	Oct 11, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are methods for using compounds that activate pyruvate kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.